SHEPARD WILLIAM R 4

What Happened William R. Shepard, a director of CME Group (CME), made open-market purchases on March 26, 2026, acquiring a total of 1,469.84 shares. The transactions consisted of 1,407.78 shares at $297.38 each ($418,646) and 62.06 shares at $297.38 each ($18,455), for a combined cost of approximately $437,101. These were purchases (transaction code P), which investors often view as a more informative — though not definitive — indicator than sales.

Key Details

• Transaction date: 2026-03-26; Filing date: 2026-03-30 (filed on the second business day after the trades, appearing timely).
• Prices: $297.38 per share for both entries.
• Share breakdown: 1,407.78 shares ($418,646) and 62.06 shares ($18,455); total 1,469.84 shares ($437,101).
• Shares owned after the transaction: not specified in the provided filing details.
• Footnote (F1): Some shares were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker; fractional-share amounts may vary slightly due to rounding.
• Transaction type: Open-market purchase (P).

Context Purchases by company insiders (directors/executives) are generally viewed positively by some retail investors because they increase the insider's stake, but they do not guarantee future stock performance. This filing documents straightforward open-market buys and includes a dividend reinvestment detail; it does not indicate option exercises, gifts, or a 10% ownership change.